The cancer-focused genetic testing services market is undergoing a transformative evolution, driven by advancements in genomic research and an increasing demand for personalized healthcare solutions. This burgeoning sector is poised to play a pivotal role in the early detection, prevention, and treatment of various cancer types, revolutionizing the way we combat this formidable disease. One …
Category Archives: Healthcare Trends
Reagent Filling Systems Market to reach US$ 18.3 billion by 2032: Increasing Investment in Healthcare Infrastructure Creating New Opportunities | FMI
The Reagent Filling Systems Market is experiencing robust growth and significant advancements in recent years. This market segment plays a critical role in the pharmaceutical, biotechnology, and diagnostic industries by automating the process of filling reagents into containers, vials, or cartridges. These systems offer a highly efficient and precise solution for handling reagents, ensuring consistent …
Hemostatic for Wound Closure Market: A Comprehensive Guide to the Anticipated 6.3% CAGR Growth by 2032
The Hemostats For Wound Closure Market is anticipated to grow at a CAGR of 6.3% from 2022 to 2032. To provide a clear knowledge of the market and the variables influencing its growth trajectory, analysts at FMI have used in-depth analysis. The research has taken into account every aspect that is anticipated to play a …
Crystal Clear Prospects: Unveiling the Trajectory of Myopia and Presbyopia Treatment Market with an 8.5% CAGR, According to FMI
The market for medical remedies for treating myopia (nearsightedness) and presbyopia (age-related farsightedness) is referred to as the “Myopia and Presbyopia Treatment Market.” These two frequent ocular refractive defects affect a sizable fraction of the world’s population. Presbyopia is characterised by the deterioration of near vision that comes with ageing, whereas myopia is a disorder …
Smart Pills Technologies Market: Anticipates Remarkable 21% CAGR Surge, Aiming for US$ 6176 Million by 2032
The Smart Pill Technologies Market is anticipated to grow at a CAGR of 21% over the course of the forecast period, from US$ 627.1 Million in 2020 to US$ 6176 Million in valuation by 2032. The Global Smart Pill Technologies Market Size study provides critical information related to the global, regional and top players including Smart Pill …
Artificial Intelligence and Machine Learning to Transform Critical Care Patient Monitoring Products Market to grow at a CAGR of 8.6% from 2022 to 2032
The Critical Care Patient Monitoring Products Market is expected to grow at a CAGR of 8.6% from 2022 to 2032. FMI, in its upcoming business report, elaborates the historical and current scenario of the global Critical Care Patient Monitoring Products Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions …
Favorable Government Policies to Support Coronavirus Immunoassay Market Growth to surpass US$ 6.9 Billion by 2032 at a 5.5% CAGR
The Coronavirus Immunoassay Market was worth US$ 3.7 Billion in 2021. By 2032, the market is anticipated to reach a value of approximately US$ 6.9 Billion, with sales increasing at a 5.5% CAGR throughout the assessment period. With an estimated 64.0% market share in 2021, immunoassay kits & reagents are in the lead. COVID-19 has a wide …
Heart Block Therapeutics Market to grow at a projected CAGR of 4.3% by 2032: Significant Growth and Innovation Driven by Aging Population and Medical Advancements | FMI
The heart block therapeutics market has witnessed significant growth and innovation in recent years, driven by the increasing prevalence of heart diseases and the continuous advancement in medical technology. Heart block, a condition characterized by abnormal electrical conduction in the heart, poses a substantial health risk and often requires medical intervention. As a result, the …
Systemic lupus erythematosus Drugs Market to grow USD 329.18 Billion by 2032 Growth Driven by Rising Prevalence, and Growing Availability of Novel Therapies | FMI
The global systemic lupus erythematosus (SLE) drugs market is expected to grow from USD 183.3 billion in 2020 to USD 329.18 billion by 2032, at a CAGR of 5% during the forecast period. The market growth is attributed to the rising prevalence of SLE, increasing awareness about the disease, and growing availability of novel therapies. …
Neurodegenerative Disease Market to Reach US$ 92 Billion by 2032, Driven by Demand for Holistic Therapies | FMI Insights
The pharmaceutical and healthcare industry that focuses on the diagnosis, treatment, and management of various neurodegenerative conditions is referred to as the “Neurodegenerative Disease Market.” The progressive degradation and dysfunction of the nervous system, which affects motor abilities, cognitive function, and general quality of life, are hallmarks of neurodegenerative illnesses. Alzheimer’s disease, Parkinson’s disease, Huntington’s …